2022 Patient Impact Awards

During 2022, Cures Within Reach will celebrate and honor:

• David Fajgenbaum’s tireless efforts not only to identify a repurposed treatment for his own rare disease, but also to study and advance this therapeutic option and others for other patients as Co-Founder of the Castleman Disease Collaborative Network and his continued efforts to encourage repurposing as well as his recent activities to find, grade and advance therapies for COVID-19.

• Incyte’s efforts in bringing ruxolitinib to patients with several different rare blood cancers and for complications following bone marrow transplant, treatments for atopic dermatitis and vitiligo, as well as supporting ongoing clinical trials using approved therapies for pediatric indications.

Read the entire press release here.  To join us in celebrating these 2022 Awardees as a volunteer, through sponsorship or in other ways, please email admin@cureswithinreach.org.

Background: Awards are given to industry leaders, scientists, philanthropists and organizations driving improvements in clinical care through repurposing at events in 2022.  These events celebrate our collective commitment to patient impact through repurposing.

Congratulations to our 2022 Patient Impact Awardees: